1. Transfusion medicine and safety
2. Prevention of transfusion-transmitted infections
3. US Department of Health and Human Services. September: bacterial risk control strategies for blood collection establishments and transfusion services to enhance the safety and availability of platelets for transfusion ‐ guidance for industry FDA‐2014‐D‐1814. Food and Drug Administration Center for Biologics Evaluation and Research. 2019. [cited 2020 Dec 03]. Available from:https://www.fda.gov/regulatory-information/search-fda-guidance-documents/bacterial-risk-control-strategies-blood-collection-establishments-and-transfusion-services-enhance.
4. US Department of Health and Human Services. February: recommendations for donor screening deferral and product management to reduce the risk of transfusion transmission of Zika virus ‐ guidance for industry. Food and Drug Administration Center for Biologics Evaluation and Research. 2016. [cited 2020 Dec 03]. Available from:http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Blood/UCM486360.pdf.
5. US Department of Health and Human Services. Recommendations for reducing the risk of transfusion‐transmitted babesiosis ‐ guidance for industry. Food and Drug Administration Center for Biologics Evaluation and Research. 2019. [cited 2020 Dec 03]. Available from:https://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/default.htm.